These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 12891096)

  • 1. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
    Hennessy KD; Green-Hennessy S; Buck JA; Miller K
    J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes In US spending on Mental Health And Substance Abuse Treatment, 1986-2005, and implications for policy.
    Mark TL; Levit KR; Vandivort-Warren R; Buck JA; Coffey RM
    Health Aff (Millwood); 2011 Feb; 30(2):284-92. PubMed ID: 21289350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for ibogaine in drug and alcohol addiction treatment.
    Donnelly JR
    J Leg Med; 2011 Jan; 32(1):93-114. PubMed ID: 21391058
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in mental health cost growth: an expanded role for management?
    Frank RG; Goldman HH; McGuire TG
    Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare and Medicaid statistical supplement.
    Health Care Financ Rev Stat Suppl; 1994; ():1-370. PubMed ID: 10142570
    [No Abstract]   [Full Text] [Related]  

  • 9. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.
    Zuvekas SH
    Health Aff (Millwood); 2005; 24(1):195-205. PubMed ID: 15647230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001-2009.
    Mark TL; Vandivort-Warren R
    Drug Alcohol Depend; 2012 Oct; 125(3):203-7. PubMed ID: 22436972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals & psychotropic drugs.
    Health Aff (Millwood); 2009; 28(3):723. PubMed ID: 19414880
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 States.
    Raghavan R; Brown DS; Allaire BT; Garfield LD; Ross RE
    Psychiatr Serv; 2014 Dec; 65(12):1445-51. PubMed ID: 25178250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the effects of financial risk on the formal treatment costs for a Medicaid population with psychiatric disabilities.
    Jones K; Chen HJ; Jordan N; Boothroyd RA; Ramoni-Perazzi J; Shern DL
    Med Care; 2006 Apr; 44(4):320-7. PubMed ID: 16565632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Washington State Access to Recovery project: effects on Medicaid costs for working age disabled clients.
    Wickizer TM; Mancuso D; Campbell K; Lucenko B
    J Subst Abuse Treat; 2009 Oct; 37(3):240-6. PubMed ID: 19339138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicaid institutional and home and community-based services expenditures for persons with ID/DD within the overall Medicaid program.
    Lakin KC; Prouty R; Alba K
    Intellect Dev Disabil; 2007 Dec; 45(6):418-21. PubMed ID: 17997620
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicaid beneficiaries using mental health or substance abuse services in fee-for-service plans in 13 states, 2003.
    Ireys HT; Barrett AL; Buck JA; Croghan TW; Au M; Teich JL
    Psychiatr Serv; 2010 Sep; 61(9):871-7. PubMed ID: 20810584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. spending for mental health and substance abuse treatment, 1991-2001.
    Mark TL; Coffey RM; Vandivort-Warren R; Harwood HJ; King EC;
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-133-W5-142. PubMed ID: 15797947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.